Viatris Inc. stock rises 1.51 percent to $14.81, outperforming market

10 articles · Updated · MarketWatch · Apr 27

On Monday, Viatris Inc. shares closed at $14.81, up 1.51%, while the S&P 500 gained 0.12% and the Dow Jones fell 0.13%.
The stock remains 10.08% below its 52-week high of $16.47, reached on February 26th, 2026.
Trading volume was 7.0 million, significantly below the 50-day average of 10.4 million, amid a mixed overall market session.

Viatris plans to deploy over $5 billion for acquisitions. What kind of deals will redefine its future?

Can Viatris's ambitious 2030 growth plan survive its current manufacturing and regulatory hurdles?

Viatris bets on ophthalmology, but will its pipeline deliver the blockbusters needed for its transformation?

One model suggests the stock is 'materially undervalued.' What is holding its market price back?

As Viatris cuts its workforce by 10%, can it maintain the innovation required to meet its goals?